Real-Time Trials Demand Real-Time Operations

Everyone in the industry is talking about what real-time clinical trials could mean for drug development: shorter timelines, earlier visibility into safety and performance signals, and higher quality. 

But to make continuous data sharing work at scale, sponsors, CROs, and research sites will need to assess how the data is captured, validated, shared, monitored, and acted upon. 

The Current Model Was Built for Delayed Data

Clinical trials still rely on workflows built around periodic review. Data is captured at the site, transferred across systems, and eventually reviewed by sponsors and regulators. 

Every handoff adds latency and risk. 

This creates both an integration and an operating model challenge. 

Real-Time Visibility Changes the Way Teams Work

Real-time trials aren’t just about giving regulators faster access to data. Continuous visibility changes how sponsors, CROs, sites, and regulators respond to that data. 

When information is available ‘now’, teams need to know: What requires action? Who owns it? And how quickly can they respond? 

Monthly monitoring, email alerts, spreadsheets, and manual reconciliation were not designed for that pace. 

Real-time data requires real-time action. 

The Foundation Is Operational, Not Technical

Technology will be essential to enabling real-time clinical trials, but implementing another system won’t solve an organization’s underlying process gaps.  

Readiness starts by examining how work actually happens today: 

  • Where does paper still exist? 
  • Where is data entered more than once? 
  • Where do teams manually reconcile information? 
  • Which systems are not connected? 
  • Where are there interdependencies? 
  • Who owns an operational exception when it occurs? 
  • How long does it currently take to review and query collected information? 
  • How quickly can the organization act on new information? 

These questions expose the difference between having connected technology and having connected operations. 

What Organizations Should Be Doing Now

Organizations preparing for the next generation of clinical trials should begin building the operational foundation before real-time models become standard. 

That means: 

  1. Move data capture closer to the source. Structured, accurate source data is the foundation for everything downstream. 
  2. Eliminate unnecessary handoffs. Every manual transfer creates latency and introduces another opportunity for error. 
  3. Define ownership of exceptions. Determine who monitors, investigates, and acts when real-time data identifies a potential issue. 
  4. Connect critical workflows. Data should move between systems without requiring teams to constantly reconcile multiple versions of the truth. 
  5. Modernize governance. Decision-making processes need to support the speed and visibility of continuous data. 

The Real Opportunity

Real-time clinical trials aren’t simply about seeing data sooner. Instead, they represent a shift in how clinical research operates. The organizations that are ready will not just have the technology to transmit data – they will have the workflows, accountability, governance, and infrastructure required to act on that data. 

That is the real operating model change. 

Real-time trials will require real-time operations. And organizations that start building that foundation now will be better positioned for whatever comes next. 

See how RealTime’s Site Operations Management System (SOMS) can help improve visibility, standardize workflows, reduce manual dependencies, and scale real-time operations. 

Access the Report

Complete the form below to access the full report.